SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-21-012704
Filing Date
2021-09-23
Accepted
2021-09-23 16:49:34
Documents
15
Period of Report
2021-09-22
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K iova-20210922x8k.htm   iXBRL 8-K 44321
2 EX-10.1 iova-20210922xex10d1.htm EX-10.1 123195
3 EX-10.2 iova-20210922xex10d2.htm EX-10.2 55401
4 EX-10.3 iova-20210922xex10d3.htm EX-10.3 62020
  Complete submission text file 0001558370-21-012704.txt   467504

Data Files

Seq Description Document Type Size
5 EX-101.SCH iova-20210922.xsd EX-101.SCH 3185
6 EX-101.LAB iova-20210922_lab.xml EX-101.LAB 16166
7 EX-101.PRE iova-20210922_pre.xml EX-101.PRE 10924
8 EXTRACTED XBRL INSTANCE DOCUMENT iova-20210922x8k_htm.xml XML 4891
Mailing Address 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070
Business Address 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070 6502607120
IOVANCE BIOTHERAPEUTICS, INC. (Filer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36860 | Film No.: 211273040
SIC: 2836 Biological Products, (No Diagnostic Substances)